Omega-3 levels for healthy school children 'well below the minimum recommended for good cardiovascular health in adults'

Omega-3 levels linked to cognition and behavior in schoolchildren: Oxford University study

By Stephen DANIELLS

- Last updated on GMT

Omega-3 levels linked to cognition and behavior in schoolchildren: Oxford University study
Blood levels of DHA and other omega-3s are directly related to measures of cognition and behavior in schoolchildren with below average reading ability, says a new study from the UK.

Data from 493 British schoolchildren also showed that the levels were also low relative to adult cardiovascular health recommendations, report researchers from the Centre for Evidence-Based Intervention at the University of Oxford.

“The finding that low-Omega-3 LC-PUFA, and DHA in particular, predict behavior and learning problems in this large sample of healthy, but underperforming children attending mainstream schools suggests that the benefits from dietary supplementation found in ADHD and related conditions may extend to a wider population,”​ they wrote in the journal PLOS ONE​.

“This question can only be addressed by well-powered intervention studies, but meanwhile, the low blood Omega-3 status found across this sample would indicate that an increased dietary intake might be beneficial on general health grounds.”

Investing in the future

Commenting independently on the results of the study, Harry Rice, PhD, VP of regulatory & scientific affairs for the Global Organization for EPA and DHA Omega-3s (GOED), told NutraIngredients-USA: "In this study, the LC O-3 status of the children was frighteningly low, particularly given that adequate levels of DHA are critical for normal brain and nervous system development. It stands to reason that these children would under-perform in school.

“Results from this study provide further evidence for the need to increase long-chain omega-3 intake in this vulnerable population, the future of tomorrow."

‘Promising’

The study follows earlier data from the DOLAB study published in PLOS last year​. Findings showed that DHA supplementation had a robust impact in aiding ‘underperforming’ children.

Speaking with NutraIngredients after the earlier publication, Dr Alex Richardson, head author and researcher of the study, told us: “These findings are really quite promising.”

Richardson explained that it is well-known and documented that the critical period for omega-3 impacts on brain function is early on; pre-natal especially.

“This is what makes the findings all the more impressive as it showed DHA impact well outside the most critical period,”​ Richardson said.

“We have shown that in the mainstream, general population, something as simple and safe as DHA can benefit reading abilities.”

Study details

For the new study, the researchers measured blood fatty acids from 493 seven to nine year olds with below average reading performance.

Results showed that DHA and EPA accounted for only 1.9% and 0.55% of total blood fatty acids, respectively.

“Concentrations below 4% EPA+DHA in red cell membranes (i.e. the Omega-3 index) are considered to signify high cardiovascular risk, and 8–12% the optimal range,”​ wrote the researchers. “The longer term implications of the very low values found in these UK schoolchildren obviously cannot be known, but give cause for concern.”

Additional number crunching revealed that lower DHA concentrations were associated with poorer reading ability, working memory, and higher oppositional behavior and emotional ability.

The study was funded by Martek Biosciences Inc (now DSM Nutritional Products).

Source: PLOS ONE
Published online ahead of print, 10.1371/journal.pone.0066697
“Low Blood Long Chain Omega-3 Fatty Acids in UK Children Are Associated with Poor Cognitive Performance and Behavior: A Cross-Sectional Analysis from the DOLAB Study”
Authors: Paul Montgomery, Jennifer R. Burton, Richard P. Sewell, Thees F. Spreckelsen, Alexandra J. Richardson

Related news

Show more

Related products

show more

Your Product Innovation Begins Here: Booth 4055

Your Product Innovation Begins Here: Booth 4055

Content provided by Effepharm Ltd | 22-Oct-2024 | Product Brochure

EffePharm will showcase innovative anti-aging solutions, featuring UthPeak™, world’s first self-GRAS approved NMNH, which boosts NAD+ levels by 10X. UthPeak™...

Algal Oil or Fish Oil: Which Should I Choose?

Algal Oil or Fish Oil: Which Should I Choose?

Content provided by GC Rieber VivoMega™ | 04-Oct-2024 | Infographic

Are you fishing for answers when it comes to omega-3s from fish oil vs. algal oil? Do you find yourself asking if EPA or DHA from fish oil is the same...

Gut and mental health struggles affect consumers

Gut and mental health struggles affect consumers

Content provided by Verb Biotics | 23-Sep-2024 | White Paper

Verb Biotics, a biotech company focused on improving health through the gut microbiome, recently completed its second annual consumer survey to assess...

Related suppliers

Follow us

Products

View more

Webinars